Premium Information is available for this item - Upgrade for $1 a day
6505-01-121-2970
Fat Emulsion Injection
6505011212970 011212970 LIPOSYN 10% 4326-01 NDC00074-4326-01
January 2023
3
Marketplace 6505-01-121-2970
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-121-2970 3+ Documents (More...)
Fat Emulsion Injection 6505011212970 LIPOSYN 10% 4326-01NDC00074-4326-01 Managed by United States NSN
Emulsion Injection 6505011212970 Charger 6130131212970 131212970 Restrictions 6505-01-121-2970 DEMIL
5940016032209 2209 Quick Disconnect Terminal 5940016032209 Terminal 5940016032209 Every Day 6505-01-121-2970
Every Day 6505-01-121 /fsg-65/fsc-6505/us 6505 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-121-2970
5940016032209 Every Day 6505-01-121-2970 6130-13-121-2970 4+ Documents https//www.nsnlookup.com /fsg
-65/fsc-6505/us 6505-01-121-2970 Fat Emulsion Injection 6505011212970 Charger 6130131212970 131212970
Restrictions 6505-01-121-2970
6505-01-121-2970 is a Fat Emulsion Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-121-2970
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-121-2970
- NASA (G65V)
- Effective Date:
- 1 Apr 1991
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-121-2970
- Part Number
- Manufacturer
- Status
- 4326-01
- Manufacturer
- 60060 - Abbott Laboratories Inc. (Active)
- Primary Buy
- Primary Buy
- NDC00074-4326-01
- 60060 - Abbott Laboratories Inc. (Active)
- Primary Buy
- Primary Buy
- LIPOSYN 10%
- 60060 - Abbott Laboratories Inc. (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-121-2970
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 2.500 Percentage, W/V Glycerin Active Ingredient And 10.000 Percentage, W/V Safflower Oil Active Ingredient And 1.200 Pct W/V Egg Phosphatides Active Ingredient
- Administration [CSGS]
- Intravenous
- Primary Container Type [CQCT]
- Bottle, Infusion
- Primary Container Content Quantity [CRLK]
- 500.000 Milliliters
- Pharmaceutical Vehicle Type [AKJQ]
- Aqueous
- Special Features [FEAT]
- With Administration Set
- Supplementary Features [SUPP]
- Medsep Item For Dod,Abbott Labs
NATO Stock Numbers Related to 6505-01-121-2970
Freight Information 6505-01-121-2970
6505-01-121-2970 has freight characteristics.. 6505-01-121-2970 has a variance between NMFC and UFC when transported by rail and the description should be consulted.